Russia's Sputnik V coronavirus vaccine authorized in 50th country, Namibia - RDIF
MOSCOW. March 11 (Interfax) - Russia's Sputnik V coronavirus vaccine has been approved in Namibia, the Russian Direct Investment Fund (RDIF) said in a statement on Thursday.
"The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus in the 50th country - the Republic of Namibia," it said.
"The Ministry of Health and Social Services of Namibia has registered Sputnik V under the emergency use authorization procedure," the RDIF said.
"Total population of 50 countries where the Russian vaccine is approved for use exceeds 1.3 billion people," it said.
"Sputnik ranks second among coronavirus vaccines globally in terms of the number of approvals issued by government regulators," the RDIF said.
Sputnik V has been approved in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, the United Arab Emirates, Iran, the Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Republika Srpska (an entity within Bosnia and Herzegovina), Lebanon, Myanmar, Pakistan, Mongolia, Bahrain, Montenegro, Saint Vincent and Grenadines, Kazakhstan, Uzbekistan, Gabon, San Marino, Ghana, Syria, Kyrgyzstan, Guyana, Egypt, Honduras, Guatemala, Moldova, Slovakia, Angola, Djibouti, the Republic of the Congo, Sri Lanka, Laos, Iraq, North Macedonia, Kenya, Morocco, and Jordan.